Arges Life Science Limited
About Company
Arges Life Science. is a sister concern of U.S.-based Arges Biolab, in Boston, Massachusetts. Our cGMP manufacturing plant is in Chittagong, Bangladesh. It takes pride in being the specialty company based on the resources provided by Arges Biolab.
Every standard operating procedure, machine-qualification protocol, API synthesis, and formulation is conceptualized and tested by Arges Biolab before it is implemented at the Arges Life Science plant in Chittagong, Bangladesh.
Our goal is to create the next generation of innovative pharmaceutical products by providing the highest quality ingredients, people and process.
Arges is basically defined by its human capital and the innovative efforts it employs. Arges has scientists who worked in some of the top notch drug research facilities (Harvard University, Pfizer, Teva, Abbott) in USA, and (Sumitomo) in Japan. It’s scientists with performance driven credential steer forward all aspects of generic drug development.
Unlike the hundreds of other pharmaceutical firms in Bangladesh, Arges Life Science is a multinational venture that leverages the unique strengths of both its local production facilities in Bangaldesh's fast-growing pharmaceutical industry and the biotechnology expertise of Arges Biolab in the United States.
Arges seeks to revolutionize the Asian pharmaceutical market by introducing a wide array of drug products and unique molecules new to Bangladesh using its expertise in dosage form design and advanced synthesis methods. Research & Development is the foundation of our philosophy of developing safe, cost-effective, high-quality medicines.
It has developed this product line by tapping the scientific capital of the highly-qualified, senior scientists of Arges Biolabs who drive product development from API to finished product, including oversight over regulatory document preparation and a comprehensive system of quality control. Every standard operating procedure, machine-qualification protocol, API synthesis, and formulation is conceptualized and tested by Arges Biolab before it is implemented at the Arges Life Science plant in Chittagong, Bangladesh.
